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ABSTRACT
EXD2 (3′-5′ exonuclease domain-containing protein
2) is an essential protein with a conserved DEDDy
superfamily 3′-5′ exonuclease domain. Recent re-
search suggests that EXD2 has two potential func-
tions: as a component of the DNA double-strand
break repair machinery and as a ribonuclease for
the regulation of mitochondrial translation. Herein,
electron microscope imaging analysis and proxim-
ity labeling revealed that EXD2 is anchored to the
mitochondrial outer membrane through a conserved
N-terminal transmembrane domain, while the C-
terminal region is cytosolic. Crystal structures of the
exonuclease domain in complex with Mn2+/Mg2+ re-
vealed a domain-swapped dimer in which the central
5−7 helices are mutually crossed over, resulting
in chimeric active sites. Additionally, the C-terminal
segments absent in other DnaQ family exonucleases
enclose the central chimeric active sites. Combined
structural and biochemical analyses demonstrated
that the unusual dimeric organization stabilizes the
active site, facilitates discrimination between DNA
and RNA substrates based on divalent cation coor-
dination and generates a positively charged groove
that binds substrates.
INTRODUCTION
EXD2 (3′-5′ exonuclease domain-containing protein 2) was
identified as a new component that plays an essential role
in mediating the repair of DNA double-strand breaks (1).
It was suggested that EXD2 might be required to facili-
tate DNA end resection during homologous recombination
by functionally interacting with theMRE11-RAD50-NBS1
(MRN) complex. Primary structure analysis revealed a 3′ to
5′ exonuclease domain belonging to the DnaQ (DEDDy)
family sharing high sequence similarity with the exonucle-
ase domain of Werner syndrome protein (WRN), an en-
zyme involved in maintaining genome stability, and recom-
binant EXD2 exhibits 3′ to 5′ exonuclease activity against
DNA in vitro (1).
However, in contrast to previous results, database analy-
sis using The Human Protein Atlas (www.proteinatlas.org)
(2), a public resource of immunofluorescence images for the
human proteome, raised the possibility that EXD2 might
be localized to mitochondria in various mammalian cell
lines such as A-431, U-2 OS and U-251 MG. Supporting
this possibility, Hensen et al. recently reported that EXD2
is predominantly associated with the mitochondrial outer
membrane (3). Meanwhile, Stracker and colleagues sug-
gested that EXD2 is localized to the inner mitochondrial
membrane (IMM) or matrix (4). According to the report,
EXD2 is a mitochondrial ribonuclease that plays impor-
tant roles in mitochondrial functions such as respiration,
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ATP production and mitochondrial translation. The sub-
location of EXD2 within mitochondria was examined us-
ing proteinaseK digestion of purifiedmitochondria in com-
bination with electron microscopy (EM) imaging follow-
ing staining with immuno-gold (4). However, such conven-
tional approaches based on protease accessibility of the
sub-mitochondrial proteome in purified mitochondria can
lead to mis-interpretation if the target protein is unexpect-
edly resistant to proteases, as demonstrated for NDUFB10
(5). Furthermore, immuno-gold EM imaging requires cel-
lular permeabilization, which occasionally degrades cellu-
lar ultrastructure (6), and treatment with immuno-goldmay
cause unintended extraction or relocalization of proteins
(7).
Interestingly, EXD2 exhibited exonuclease substrate dis-
crimination activity depending on the metal cofactors coor-
dinated (4). In the presence of MnCl2, EXD2 displays com-
parable activity toward DNA and RNA substrates, but ac-
tivity toward DNA substrates is significantly reduced when
MgCl2 is used as a cofactor. This is an interesting result be-
cause substrate discrimination via divalent cations bound
to exonucleases is a novel feature shown only for EXD2.
Even inWRNexonuclease, which shares high sequence sim-
ilarity with EXD2, metal cofactor-driven substrate discrim-
ination has not been observed (8,9). Moreover, given that
EXD2 acts as a ribonuclease in mitochondria rather than
the nucleus, this could be advantageous and allow EXD2 to
modulate its activity against DNA or RNA (4). However,
it remains unknown exactly how the exonuclease activity
of EXD2 toward DNA substrates is specifically limited in
the presence of the Mg2+ cation, considered the likely phys-
iological metal ion within cells. Therefore, molecular-level
studies on EXD2 are needed to explore these distinctive fea-
tures.
In the present study, we demonstrated that EXD2 is an
outer mitochondrial membrane (OMM) protein anchored
to the membrane through the N-terminal transmembrane
(TM) domain, while most of the functional region, includ-
ing the exonuclease domain, faces the cytosol. Furthermore,
we determined crystal structures of the exonuclease domain
of EXD2 in complex withMn2+/Mg2+ and (d)GMP, reveal-
ing a novel molecular mechanism by which EXD2 can dis-
tinguishDNAorRNA substrates depending onmetal coor-
dination, unlike other DnaQ family exonucleases reported
to date.
MATERIALS AND METHODS
Mammalian cell culture and transfection
HEK293 cells from the Korean Cell Line Bank (Seoul, Ko-
rea) were cultured in Dulbecco’s modified Eagle’s medium
(DMEM; Gibco) supplemented with 10% fetal bovine
serum (FBS), 50 units/ml penicillin and 50 g/ml strep-
tomycin at 37◦C under 5% CO2. HeLa cells from the Ko-
rean Cell Line Bank were cultured in the same conditions.
Cells were transfected at 60−80% confluence using Lipofec-
tamine 2000 (Life Technologies) according to the manufac-
turer’s instructions.
Fluorescence microscopy imaging
At 18−24 h after transfection in HeLa cells, the medium
of the EXD2-V5-APEX2-transfected sample was changed
to fresh growth medium containing 500 M biotin-phenol.
This culture was incubated for 30 min and labeled accord-
ing to a previously published protocol (10). Next, H2O2
was added to a final concentration of 1 mM, and the plate
was gently agitated for 1 min at room temperature. The re-
action was quenched by washing twice with Quencher so-
lution consisting of Dulbecco’s phosphate-buffered saline
(DPBS) containing 5 mM Trolox, 10 mM sodium azide
and 10 mM sodium ascorbate. The biotin labeling step was
omitted for Non-APEX2 samples. Biotin-labeled and non-
labeled cells were fixed with 4% paraformaldehyde. Cells
were then washed with DPBS and permeabilized with cold
methanol at−20◦C for 5 min. Cells were washed again with
DPBS and blocked for 1 h with blocking solution consisting
of 2% bovine serum albumin (BSA) in TRIS-buffered saline
with Tween 20 (TBST) at room temperature.
To detect APEX2-fusion expression, cells were incubated
with both mouse anti-V5 antibody (Invitrogen, cat. no.
R960-25, 1:5000 dilution) and rabbit anti-TOM20 (Santa
Cruz, cat. no. sc-11415, 1:200 dilution) as a mitochondrial
marker for 1 h at room temperature. To detect Flag-tagged
EXD2 expression, cells were incubated with both mouse
anti-Flag antibody (Sigma Aldrich, cat. no. F1804, 1:3000
dilution) and rabbit anti-TOM20 for 1 h at room tem-
perature. After washing with TBST, cells were simultane-
ously incubated with secondary Alexa Fluor 568 goat anti-
mouse IgG (Invitrogen, cat. no. A-11004, 1:1000 dilution)
and Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen, cat.
no. A-11008, 1:1000 dilution) for 30 min at room tempera-
ture. SA-Alexa Fluor 647 IgG (Invitrogen, cat. no. S32357,
1:1000 dilution) was incubated with biotin-labeled samples
in dialyzed blocking solution. Cells were then washed with
TBST and maintained in DPBS on ice for imaging using an
FV1000SPD instrument (Olympus) at the UNIST Optical
Biomed Imaging Center (UOBC) in the Ulsan National In-
stitute of Science and Technology (UNIST), Korea.
Transmission electron microscopy (TEM) imaging
Cells transiently expressing EXD2-V5-APEX2 or
EXD21–37-V5-APEX2 were grown in plastic six-well
plates (Falcon, 353078) to 90% confluence. Cells were
fixed and stained with diaminodenzidine (DAB) according
to a previously published method (5). Briefly, cells were
fixed using 2% glutaraldehyde and 2% paraformaldehyde
in 0.1 M sodium cacodylate buffer pH 7.4 over 30−60
min. Unreacted glutaraldehyde was quenched by 20 mM
glycine and cells were washed again in cold buffer. Freshly
diluted 1 mg/ml (2.8 mM) DAB and 10 mM H2O2 in
phosphate-buffered saline (PBS) were added. After 20
min, cells were again washed with PBS. Post-fixation was
performed using 2% (w/v) osmium tetroxide (Electron
Microscopy Sciences) for 40 min on ice and cells were
rinsed with chilled distilled water. Cells were brought to
room temperature, washed with distilled water, carefully
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min. The pellet was dehydrated in a graded ethanol series
(50−100%) for 15 min for each step. The sample was
then mixed 1:1 (v/v) with EMBED-812 resin (Electron
Microscopy Sciences) and anhydrous ethanol for 1 h. The
mixture was incubated overnight in 2:1 (v/v) resin and then
exchanged with 100% resin for 2 h before transferring to
fresh resin, followed by polymerization at 60◦C for 24 h.
Embedded cell pellets were cut with a diamond knife into
50 nm sections and imaged on a FEI-Tecnai G2 Spirit Bio
Twin TEM instrument (operated at 120 kV) at the Korea
Basic Science Institute in Chuncheon, Korea.
TOM20-pBirA stable cell line selection, culturing and label-
ing
Flp-In T-REx 293 cells (Life Technologies) were cultured
under the same conditions as HEK293 cells. Stable cell
generation, culturing and labeling were performed accord-
ing to previously published methods (5). Briefly, stable cell
lines were generated by co-transfection with the pcDNA
5/FRT/TO expression construct and the pOG44 plasmid
(1:9). After 24 h of transfection, cells were treated with
an appropriate concentration of hygromycin B (100−200
g/ml). Media containing hygromycin B were changed ev-
ery 3−4 days. After 2−3 weeks, 3−4 colonies were picked
and cultured continuously. To induce protein expression
and biotin labeling of stable cells, cells at 60−80% con-
fluence were treated with 100 ng/ml doxycycline (Sigma
Aldrich) and 50 M biotin. After incubation for 18−24 h,
cells were lysed for subsequent analyses.
TOM20-pBirA mass spectrometry (MS) sample preparation
MS sample preparation was carried out according to a pre-
viously published method (11). Briefly, after biotin label-
ing overnight, cells were washed several times with DPBS
and lysed with 1.5 ml of RIPA lysis buffer, 1× protease in-
hibitor cocktail (Sigma Aldrich, cat. no. P8849) and 1 mM
phenylmethylsulphonyl fluoride (PMSF) for 10 min at 4◦C.
Lysates were clarified by centrifugation and samples from
two T75 flasks were combined (∼3 ml).
For removal of free biotin, 3 ml of cell lysate was fil-
tered with an Amicon filter (MerckMillipore, UFC801096)
three times using PBS containing 1 mMPMSF and 1× pro-
tease inhibitor cocktail. The final ∼1 ml concentrated cell
lysate was transferred to a 1.5 ml Lobind tube and 300 l
of washed SA-beads (Pierce) were added. After rotating for
1 h, beads were washed twice with PBS, and after removing
PBS, samples were denatured in 100 l denaturing solution
(6 M urea, 2 M thiourea, 10 mM HEPES). The solution
was reduced using 20 l of 100 mM dithiothreitol (DTT)
in 50 mM ammonium bicarbonate (ABC) at 56◦C. Alky-
lation was performed by adding 35 l of 300 mM iodoac-
etamide in 50 mM ABC in the dark. The sample was di-
luted with 50 mM ABC to 1 ml. Trypsin digestion was per-
formed by adding 8 l of 1 mg/ml trypsin. The solution
was incubated at 37◦C with shaking at 900 rpm overnight.
Beads were washed with PBS four times and eluted by boil-
ing at 95◦C for 10 min after adding 250 l of 95% for-
mamide and 10mMEDTA (pH8.2), and 750l of 3% (v/v)
acetonitrile/0.1% (v/v) formic acid was added to a final vol-
ume of 1ml. The solution was desalted using a Varian Bond
ELUT column (Agilent, 12109301).
MS detection of labeled peptides and data processing
An LTQ-Orbitrap mass spectrometer (Thermo, Bremen,
Germany) equippedwith a nanoelectrospray ion source was
employed for MS detection. All MS analyses and data pro-
cessing were performed as described previously (11).
Cloning, protein expression and purification
DNA fragments encoding a highly soluble construct of hu-
man EXD2 (residues 76−564, tEXD2) and the 3′-5′ exonu-
clease domain (residues 76−295, EXD2-exo) were ampli-
fied by PCR using Homo sapiens cDNA as template and
cloned into the pcDNA5, pET28b-SMT3 and pETDUET-
1 vectors. The resulting pcDNA5 constructs were used in
mammalian transfection for imaging and pull-down exper-
iments. The pETDUET-1 vector was previously modified
to include a tobacco etch virus (TEV) protease cleavage
site before the first amino acid of the EXD2 protein. Ex-
pression plasmids were transformed into Escherichia coli
BL21 (DE3) competent cells, protein expression was in-
duced with 0.3 mM isopropyl--D-1-thiogalactopyranoside
(IPTG) when cells reached an absorbance at 600 nm
(OD600 nm) of 0.6 and culturing was continued at 18◦C for
18 h. Cells were harvested by centrifugation at 3200 × g
for 18 min and resuspended in buffer containing 25 mM
sodium phosphate pH 7.8, 400 mM sodium chloride and
10 mM imidazole. After cell lysis by sonication, tEXD2
and EXD2-exo proteins were purified by Ni2+-immobilized
metal affinity chromatography (IMAC). The His6-SMT3
tag of tEXD2 and theHis6 tag of EXD2-exowere cleaved by
Ulp1 protease and TEV protease at a ratio of 1:500 and 1:30
(w/w), respectively, during dialysis against 25 mM TRIS-
HCl, pH 7.5, 150 mMNaCl and 4 mM -mercaptoethanol
at 4◦C overnight. Cleaved tags and non-cleaved fusion pro-
teins were removed by a second round of Ni2+-IMAC. For
further purification, proteins were applied to a Superdex
200 column (GE Healthcare) equilibrated with 25 mM
TRIS-HCl, pH 7.5, 150mMNaCl and 5mMDTT. Proteins
were concentrated to 10 mg/ml and flash-frozen at −80◦C
for later use. All point mutants and deletion mutants were
generated by PCR-based mutagenesis, and mutations were
confirmedwithDNA sequencing. All mutants were purified
as described above.
Crystallization and structure determination
Crystals grew when EXD2-exo was mixed with an
equal volume of reservoir liquor containing 18%
(w/v) polyethylene glycol (PEG) 8000, 100 mM 2-(N-
morpholino)ethanesulfonic acid, pH 6.0, 0.2 M calcium
acetate and 5 mM DTT by the hanging-drop vapor dif-
fusion method at 4◦C. Crystals were cryoprotected by
transferring into a reservoir solution augmented with 30%
(v/v) ethylene glycol and flash-frozen in liquid nitrogen.
X-ray diffraction data were collected at beamline 5C of the
Pohang Accelerator Laboratory at 100 K. The best crystals
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processed using HKL2000 (12). Phases were calculated by
molecular replacement using Phaser in the Phenix suite
(13) with the coordinates of WRN-exo (PDB ID: 2FBT)
as a search model. Phaser found two EXD2 molecules in
the asymmetric unit of the P212121 space group. Model
building and refinement were performed using Coot (14)
and Phenix refine (15), respectively. The Rfree of the refined
model was 21.95%. The following residues of EXD2-exo
were disordered in the electron density map and therefore
not modeled: residue 76, residues 219−222, residues
261−274 and residue 295 in the first copy; residue 76,
residues 219−223, residues 261−274 and residues 293−295
in the second copy.
To solve the metal-coordinated structures, crystals of
EXD2-exo were transferred to reservoir solution supple-
mented with 20−50 mM MnCl2 or MgCl2 and 5 mM
dGMP or GMP for at least 1 day, and flash-frozen in liq-
uid nitrogen. Structures were solved by difference Fourier
methods. To reduce the effect of model bias, we refined the
protein chains without water molecules and ions using sim-
ulated annealing before calculating difference maps for de-
tection of positive peaks corresponding to ions and solvent
molecules. Model building and refinement were performed
as described above. Detailed crystallographic data and data
processing and refinement statistics are summarized in Sup-
plementary Table S1.
In vitro exonuclease activity assay
In vitro nuclease activity assays were conducted as reported
previously (1). In our experiments, DNA or RNA sub-
strates were labeled using 5-fluorescein amidite (5-FAM)
at the 5′ end instead of [γ -32P] 5′ labeling. DNA or RNA
substrates at a concentration of 0.25 M were incubated
with 0.05−0.2 M or 0.5−1.5 M tEXD2, or 0.5−2 M
or 20−60 M EXD2-exo, for 30 min at 37◦C in reac-
tion buffer consisting of 20 mM HEPES-KOH, pH 7.5,
50 mM KCl, 0.5 mM DTT, 0.05% (v/v) Triton X-100, 0.1
mg/ml BSA, 5% (v/v) glycerol, 1 mM ATP and 5 mM
metal ions (MnCl2, MgCl2, ZnCl2 or CaCl2) or without
metals. After reaction, products were separated by non-
denaturing 15% TRIS/Borate/EDTA-polyacrylamide gel
electrophoresis (TBE-PAGE) and fluorescence was detected
using an ImageQuant LAS 4000 instrument (GE Health-
care).
Size exclusion chromatography (SEC) analysis
Analysis of the relativemolecularmass (Figures 2C and 3D;
Supplementary Figure S4A) was carried out by SEC. Pro-
teins were concentrated to 15−20 mg/ml and injected onto
a Superdex 200 16/60 column (GEHealthcare) equilibrated
with buffer containing 25 mM TRIS-HCl, pH 7.5, 150 mM
NaCl and 5 mM DTT.
Pull-down assay
For pull-down assays, cells were prepared in a six-well plate.
Full-length human EXD2-V5-Avitag (1000 ng), EXD2-
Flag (1000 ng) and BirA-NES (500 ng) were co-transfected
in HEK293 cells. After overnight biotinylation following
addition of 10Mbiotin, cells were lysedwith 200l of Cell
Extraction Buffer (Life Technologies, cat. no. FNN0011)
containing 1× protease inhibitor cocktail (Sigma Aldrich,
cat. no. P8849) and 1 mM PMSF for 30 min at 4◦C. Lysates
were transferred into Eppendorf tubes, vortexed for 2 min
and clarified by centrifugation at 15 000 × g for 10 min at
4◦C.
A 20l of SAmagnetic beads (Invitrogen, cat. no. 88816)
were incubated with 170 l of cell lysate for 1 h. The flow-
through (FT) fraction was retained and beads were washed
three timeswithCell ExtractionBuffer. BiotinylatedEXD2-
V5-Avitag was elutedwith 2×Laemmli buffer (BioRad, cat.
no. 161-0737) supplemented with 20 mM DTT and 2 mM
biotin by heating to 95◦C for 10 min. Crude and elution
samples were separated by 10% sodium dodecyl sulphate
(SDS)-PAGE and transferred to a nitrocellulose membrane
that was subsequently stained with 0.1% Ponceau S in 5%
acetic acid/water for 10 min. After blocking with 2% (w/v)
BSA and 0.1% Tween 20 in TBST at 4◦C overnight or at
room temperature for 1 h, blots were immersed in anti-
V5 (Invitrogen, cat. no. R960-25, 1:5000 dilution) or anti-
Flag (Sigma Aldrich, cat. no. F1804, 1:3000 dilution) in
blot blocking buffer at room temperature for 60 min, then
rinsed with blot blocking buffer four times for 5 min each
time. Blots were then immersed in secondary antibody (anti-
mouse-HRP, BioRad, cat. no. 1721011) in blot blocking
buffer for between 30 min and 1 h at room temperature.
Membranes were then washed again for 4 × 5 min in TBST
before imaging with Clarity reagent (BioRad) on a G:BOX
Chemi XRQ instrument (Syngene).
Circular dichroism (CD) spectroscopy
Secondary structures of EXD2-exo, EXD276–284 and
EXD276–260 were monitored by CD spectroscopy on a
Jasco J-815 instrument (Jasco, UK) from 190 to 260 nm.
Conformational changes were also monitored by CD
spectroscopy with temperature scanning from 25 to 90◦C
over a 13 min period with detection at 222 nm. Protein
samples for wavelength scans (0.2 mg/ml) and temperature
scans (1 mg/ml) were prepared in 25 mM sodium phos-
phate pH 7.5 with 150 mM sodium fluoride and 5 mM
-mercaptoethanol.
RESULTS
EXD2 is a mitochondrial outer membrane protein facing the
cytosol
Hydropathy plot analysis strongly indicated that EXD2
might contain a single TM domain comprising residues
1−37 at theN-terminus (Supplementary Figure S1A). Since
several previous studies reported that the N-terminal single
TM domain could function as a signal motif for targeting
to mitochondria (16,17), we tested whether this domain is
crucial for mitochondrial targeting of EXD2. For this ex-
periment, we generated EXD2-Flag (Flag-tagged at the C-
terminus) constructs and expressed them in cultured cells
(Supplementary Table S2). Figure 1A shows that EXD2-
Flag was obviously targeted to mitochondria, overlapping
with TOM20 (Pearson correlation, R = 0.94). By contrast,
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Figure 1. EXD2 has an N-terminal single transmembrane (TM) domain and is localized to the outer mitochondrial membrane (OMM). (A) Confocal
microscopy imaging of EXD2-Flag in HeLa cells. The green channel (anti-TOM20) is a mitochondrial marker, and the red channel (anti-Flag) is for
analysis of EXD2-Flag expression. Pearson correlation coefficient (R) = 0.94; scale bar = 10 m. (B) Confocal microscopy imaging of EXD2-V5-APEX2
in HeLa cells. The green channel (anti-TOM20) is a mitochondrial marker, the red channel (anti-V5) is for analysis of EXD2-V5-APEX2 expression, and
the magenta channel is the biotin-phenol labeling pattern; scale bar = 10 m. (C) Electron microscopy (EM) imaging of EXD2-V5-APEX2 using the
APEX2-EM method; scale bar = 1 m. (D) Confocal microscopy imaging of TOM20-pBirA-HA expression in HeLa cells. The green channel (anti-HA)
was used to analyze enzyme expression, the red channel (streptavidin, SA-AF568) to analyze the biotinylation pattern, and the blue channel to analyze the
mitochondrial marker mito-BFP; scale bar = 10 m. (E) Tandem mass spectrometry (MS/MS) spectra of biotin-labeled EXD2 peptides. Biotin-labeled
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targeted tomitochondria (Supplementary Figure S1B), and
the resulting correlation with TOM20 was low (R = 0.43).
We also checked that EXD238–621-Flag, which includes the
N-terminal TM domain-deleted EXD2 sequence, was also
nuclear-localized in mammalian (HeLa) cells (Supplemen-
tary Figure S1C). This result indicates that the predicted
N-terminal TM domain of EXD2 might play an important
role in mitochondrial targeting, as shown for other signal-
anchored proteins such as TOM20 or AKAP1 in which the
N-terminal single TM domain acts as a signal-anchor pep-
tide at the OMM (16,17).
To investigate the sub-mitochondrial localization of
EXD2 in more detail, constructs encoding EXD2-V5-
APEX2 and EXD21–37-V5-APEX2 were expressed in HeLa
cells, which were stained with streptavidin (SA)-AF647
after biotinylation. As shown in Figure 1B, EXD2-V5-
APEX2 was tightly localized to mitochondria and over-
lapped strongly with TOM20. However, APEX-mediated
biotinylated pattern by EXD2-V5-APEX2 was not tightly
localized to mitochondria and was instead diffusely dis-
tributed in the cytosol. We also observed a similar dif-
fuse pattern for biotinylated EXD21–37-V5-APEX2 (Sup-
plementary Figure S1D). This diffuse biotin labeling pat-
tern in mitochondria was previously observed for several
mitochondrial POI (protein of interest)-APEX2 constructs
in which the C-terminus of POIs is localized to the out-
side of the IMM (10). To confirm whether EXD2 is local-
ized to themitochondrial inter-membrane space (IMS) or at
the OMM, we prepared EM samples of EXD2-V5-APEX2
andEXD21–37-V5-APEX2 by following a protocol reported
previously for APEX2-EM (18). As shown in Figure 1C,
most diaminobenzidine (DAB) staining from EXD2-V5-
APEX2 was observed at the OMM. Furthermore, the EM
results for EXD21–37-V5-APEX2 yielded a similar OMM
pattern (Supplementary Figure S1E). These results strongly
indicate that the N-terminal single TM domain of EXD2 is
incorporated at the OMM as a signal-anchor domain.
To further confirm the localization of endogenous EXD2
in the OMM, we employed Spot-BioID proximity labeling,
which facilitates profiling of biotin-labeled peptides (11).
This method can identify directly biotinylated protein can-
didates that can be considered as proximal proteins of POI-
pBirA. We performed in situ biotinylation of OMM pro-
teins using TOM20-pBirA, in which pBirA is located at the
cytosolic face of the OMM (Figure 1D). After biotin label-
ing, total biotinylated proteins and peptides were enriched
and analyzed by mass spectrometry (MS). Five lysine sites
(K46, K221, K295, K562 and K611) of endogenous EXD2
were reproducibly biotinylated by TOM20-pBirA, and la-
beled residues are within the C-terminal region of the pre-
dicted TMdomain, suggesting that theC-terminal region of
EXD2, including the exonuclease domain, functions on the
cytosolic face of the OMM (Figure 1E and Supplementary
Figure S2).
To corroborate the results of proximity labeling, we per-
formed cellular fractionation experiments of HEK293T
cells. Endogenous EXD2 was clearly enriched within
the mitochondrial fraction, along with mtSSB1 (a well-
characterized mitochondrial matrix protein) and TOM22
(a protein localized in OMM) (Supplementary Figure S1F).
While mtSSB1 were resistant to proteinase K treatment of
the mitochondrial fraction, both EXD2 and TOM22 were
degraded in similar conditions, consistent with localization
of EXD2 in OMM (Supplementary Figure S1F). Taken to-
gether, our data clearly support the notion of EXD2 localiz-
ing at the OMM with signal anchored transmembrane do-
main.
Characterization and structure determination of EXD2
Previous biochemical studies showed that EXD2 exhibits a
3′ to 5′ exonuclease activity (1,4). To further characterize
the exonuclease activity of EXD2 in vitro, we constructed a
truncated version of EXD2 (residues 76−564, subsequently
designated tEXD2; Figure 2A) that is reported to exhibit
robust expression in vitro (1) and purified the protein to
homogeneity. To test the exonuclease activity of tEXD2,
single-stranded 50 nt DNA oligonucleotides labeled with
5-fluorescein amidite (5-FAM) at the 5′ end were incu-
bated with tEXD2 for 30 min, and reaction products were
separated by 15% non-denaturing TRIS/Borate/EDTA-
polyacrylamide gel electrophoresis (TBE-PAGE) and sub-
jected to fluorescence detection. Figure 2B shows that
tEXD2 possesses 3′ to 5′ exonuclease activity. Interestingly,
tEXD2 displayed metal-specific activity, with strong exonu-
clease activity only in the presence of Mn2+, and no ex-
onuclease activity with other divalent metal ions such as
Mg2+, Zn2+ and Ca2+. From these results, we concluded
that tEXD2 is aMn2+-specific 3′ to 5′ exonuclease targeting
DNA substrates. Additionally, tEXD2 exhibited enzymatic
activity against RNA substrates in the presence of both
Mn2+ and Mg2+ ions, although activity was again stronger
with Mn2+ ions (Supplementary Figure S3A).
To obtain further structural insight into the metal-
specific exonuclease activity of EXD2,we attempted to crys-
tallize the human tEXD2 protein. However, despite exten-
sive screening, we failed to grow crystals suitable for X-
ray diffraction experiments. Combined limited proteolysis
and sequence conservation analyses of EXD2 from various
species identified a compact exonuclease domain of EXD2
comprising residues 76−295 (designated EXD2-exo; Fig-
ure 2A). Size exclusion chromatography (SEC) analysis re-
vealed that recombinant EXD2-exo was present in both
monomeric and dimeric forms in an ∼50:50 ratio in so-
lution (Figure 2C). Self-oligomerization was also appar-
ent for tEXD2 when analyzed by SEC and analytical ul-
tracentrifugation (AUC; Supplementary Figure S4). Inter-
estingly, EXD2-exo collected from the monomer fractions
displayed substantially reduced exonuclease activity in the
presence of Mn2+ ions. For RNA substrates, monomeric
EXD2-exo was inactive regardless of Mn2+ or Mg2+ metal
ions, whereas dimeric EXD2-exo possessed activity compa-
rable with that of tEXD2 against both DNA andRNA sub-
strates (Figure 2D and Supplementary Figure S3B).
We only obtained crystals of dimeric EXD2-exo, and
these crystals diffracted to 1.6 A˚ resolution using syn-
chrotron radiation. The crystals belong to space group
P212121 and contain two EXD2-exo molecules in the asym-
metric unit. Amolecular replacement solutionwas obtained
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Figure 2. Crystal structure of EXD2-exo. (A) Schematic diagram showing the domain structure of human EXD2 and truncated constructs used in this
study. Biochemical analyses revealed that EXD2 is anchored to the mitochondrial outer membrane (OMM) by a single TM domain at the N-terminus. The
cytoplasmic portion of EXD2 contains a 3′-5′ exonuclease domain (residues 76−295) and a predicted HNH-like domain (residues 408−470). Based on the
crystal structure, the 3′-5′ exonuclease domain consists of a canonical DEDDy domain followed by an additional C-segment; IMS, mitochondrial inter-
membrane space; OMM, mitochondrial outer membrane; TM, transmembrane domain. (B) Metal cation-dependent 3′-5′ exonuclease activity of tEXD2.
A 0.2 M sample of tEXD2 was incubated with 0.25 M 5-fluorescein amidite (FAM)-labeled 50-mer single-stranded DNA (ssDNA) for 30 min at 37◦C
in 20 mM HEPES-KOH pH 7.5, 50 mM KCl, 0.5 mM dithiothreitol (DTT), 0.05% Triton X-100, 0.1 mg/ml BSA, 5% glycerol, 1 mM ATP and 5 mM
metal ions (MnCl2, MgCl2, ZnCl2 or CaCl2) or without metal. Non-denaturing TRIS/Borate/EDTA-polyacrylamide gel electrophoresis (TBE-PAGE)
showed that tEXD2 cleaves 5-FAM-labeled ssDNA only in the presence of MnCl2. (C) Size exclusion chromatography (SEC) of EXD2-exo. EXD2-exo
proteins were injected onto a Superdex 200 column (GEHealthcare) equilibrated in 25 mMTRIS-HCl, pH 7.5, 150 mMNaCl and 5 mMDTT. EXD2-exo
was eluted in both dimeric and monomeric forms at an ∼50:50 ratio. Protein standards are shown above the chromatogram curves to compare the relative
molecular mass (ferritin, 440 kDa; aldolase, 158 kDa; conalbumin, 75 kDa; ovalbumin, 44 kDa; carbonic anhydrase, 29 kDa; ribonuclease A, 13.7 kDa).
(D) Metal cation-dependent 3′-5′ exonuclease activity of EXD2-exo. A 1.5 M sample of each protein was mixed with 0.25 M 5-FAM-labeled 50-mer
ssDNA under the same conditions as in panel (B). (E) Overall structure of EXD2-exo in the crystallographic asymmetric unit. EXD2-exo forms a dimer
through 2-fold rotational symmetry. Protomers are colored red and gray. The crystal structure was determined by molecular replacement (MR) and refined
to 1.6 A˚ resolution (Supplementary Table S1). Three dimeric interfaces are highlighted with black dotted boxes (see also Supplementary Figure S7 for
details). Yellow spheres indicate sodium ions bound to the active sites of EXD2-exo. (F) Ribbon diagram showing the DEDDy exonuclease domain of
EXD2-exo. The EXD2-exo protomer consists of six -strands and eight -helices. The catalytic site of EXD2-exo is formed by the association of a central
domain comprising 1−6 and 1−5 of one EXD2-exo molecule, and 6′−7′ from the other molecule in the EXD2-exo dimer. A chimeric active site
is formed by crossing over of the extended 5 helices between the two protomers of the dimer. The C-segments comprising swapped 8 helices and a
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which shares 28% sequence identity with EXD2-exo, as a
search model. Successive rounds of model building and re-
finement resulted in anRwork/Rfree of 0.192/0.220with good
stereochemistry (Supplementary Table S1).
Structure of EXD2-exo
Consistent with the biochemical analyses, EXD2-exo forms
a dimer with overall dimensions of ∼91.0 × 42.7 × 39.3
A˚, in which two molecules are arranged with a 2-fold rota-
tional symmetry around the axis perpendicular to the plane
(Figure 2E). No discernible differences were found in the
two molecules, which have a root-mean square deviation
(RMSD) of∼0.253 A˚ for all C atoms. Each molecule con-
sists of eight -helices (1−8) and a six-stranded (1−6)
-sheet that folds into a canonical DnaQ-like exonuclease
domain and contains two active site Na+ ions, neither of
which supports nuclease activity (Figure 2E and F; Sup-
plementary Figure S5). Surprisingly, the 5−7 helices are
exchanged between molecules in the EXD2-exo dimer, re-
sulting in a domain-swapped structure. Most interestingly,
both exchanged 7 helices play a pivotal role in complet-
ing the exonuclease active sites in the opposing molecule
in the EXD2-exo dimer. This unexpected structural per-
spective revealed why the exonuclease activity was signif-
icantly reduced in the EXD2-exo monomer (Figure 2D).
This unusual conformation is a novel feature that is absent
in other DnaQ family exonucleases. Although the structure
of the EXD2-exo monomer itself cannot be exclusively su-
perimposed with the exonuclease domains of DnaQ fam-
ily proteins (RMSD > 3.0 A˚), each complete composite
monomeric exonuclease domain present in the EXD2-exo
dimer strongly resembles the exonuclease domains ofWRN,
Klenow fragment (KF) and Ribonuclease D (Rnase D),
with RMSD values for all C atoms of 1.035, 2.273 and
2.212 A˚, respectively (Figure 3B and Supplementary Figure
S6).
The crystal structure revealed that three direct interfaces
are involved in the self-association of EXD2-exo, resulting
in a buried surface area of 4024 A˚2 (Figure 2E and Supple-
mentary Figure S7). The first interface is generated by a 2-
fold arrangement of helices 5−7 in the EXD2-exo dimer.
In particular, helices 5 and 5′ from opposing molecules
are organized in an antiparallel fashion, resulting in the for-
mation of a coiled coil-like dimer (Figure 2E and Supple-
mentary Figure S7, top). In addition, helix 5 also contacts
both helix 6′ and the C-terminus of helix 7′ in a parallel
fashion behind the 5–5′ interface (Supplementary Fig-
ure S7, top left). Notably, the C-terminal ends of helices 7
and 7′ face each other, generating a precise 2-fold center in
which the side chains of the twoHis256 residues are stacked
side by side (Supplementary Figure S7, top right). The sec-
ond interface is formed by an extensive contact between
the exchanged loop (residues 227−237) followed by helix
7 (residues 238−260) and the central -sheet of the active
site in the opposingmolecule, as described above (Figure 2E
and Supplementary Figure S7, bottom left). In the third in-
terface, the C-terminal fragment of EXD2-exo (designated
as theC-segment) plays a critical role in the interaction, sup-
porting structural integrity (Figure 2E and Supplementary
Figure S7, bottom right). The active exonuclease domain of
WRN-exo ends at residue 230, at the C-terminal end of he-
lix 7 (9), whereas the equivalent helix 7 in EXD2-exo is
followed by a flexible loop (residues 261−274) that is dis-
ordered, and this in turn is followed by the short helix 8
(residues 275−284) and a well-ordered loop (C-loop) com-
prising residues 285−294 (Figure 2E and F; Supplementary
Figure S7, bottom right). Surprisingly, the two additional
C-segments mutually enclose each other in the EXD2-exo
dimer, and this clearly stabilizes the dimeric organization
and assists the formation of stable active sites. In particular,
the 8 helix associates with the C-terminus of 1′and 6′
and 5′ of the opposing molecule in the dimer (Figure 2F
and Supplementary Figure S7, bottom right).
Residues 219−222 from the loop connecting helices 6
and7, and residues 261–274 predicted to form an extended
loop, are disordered in the structure. As discussed below,
these apparently flexible regions might facilitate the binding
of substrates and regulation of activity, respectively.
Extended helix 5 of EXD2-exo confers a domain-swapped
structure
Sequence alignment of EXD2-exo with DnaQ family ex-
onucleases including WRN, KF, RNase D, Exonuclease 1
(EXO1) andDNApolymerase III subunit epsilon (DPO3E)
revealed that helix 5 of EXD2 is extended by five more
residues (198NNLLC202) than in other compared exonu-
cleases (Figure 3A) (9,19–22). This extended sequence is
conserved in all EXD2 family members above metazoan
species, suggesting that self-association through helix 5
might be evolutionally conserved and structurally impor-
tant for EXD2 function (Supplementary Figure S5). The
extended helix 5 clearly affects the overall conformation,
and likely induces domain-swapped dimerization in EXD2-
exo. Helices 5 and 6 of EXD2-exo are organized in an
antiparallel manner, unlike the equivalent helices in other
DnaQ family exonucleases, which are arranged in parallel
pairs (Figure 3B and C; Supplementary Figure S6). Helices
6′ and 7′ from the opposing molecule in the EXD2-exo
dimer can be perfectly superimposed with helices 5 and
7 of WRN-exo, suggesting that the dimeric configuration
of EXD2-exo might not affect exonuclease activity (Figure
3C).
To examine the role of the 5 helix in dimer formation,
we performed mutagenesis to disrupt the conformation of
helix 5. Figure 3D shows that both single point (N198P)
and deletion (residues 198−201) mutants of EXD2-exo
eluted from the SEC column only as monomers, suggest-
ing that the extended helix 5 is important for forming a
domain-swapped dimer, as would be expected based on the
crystal structure. We further tested if the mutants retained
the ability to digest DNA, and observed that both mutants
impaired exonuclease activity (Figure 3E). This result sug-
gests that the formation of a swapped dimer is required for
the catalytic activity of EXD2-exo.
Next, we examined whether full-length EXD2 also self-
associates in live cells using pull-down assays (Figure 3F).
For this experiment, we prepared mammalian expression
constructs for EXD21–621 (full EXD2 sequence)-V5-Avitag
(AP) and EXD21–621-Flag constructs. These constructs
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Figure 3. The extended 5 helix stabilizes a novel dimeric conformation in EXD2-exo. (A) Structure-based sequence alignment of helices 5 and 6 of
human EXD2 and equivalent helices in other DnaQ family exonucleases including Werner syndrome ATP-dependent helicase (WRN, PDB ID: 2FBT),
DNA polymerase I Klenow fragment (KF, PDB ID: 1KFS), ribonuclease D (RND, PDB ID: 1YT3), exonuclease 1 (EXO1, PDB ID: 1FXX) and DNA
polymerase III subunit epsilon (DPO3E, PDB ID: 1J53). Sequence alignment reveals that the 5 helix is extended by five additional residues in EXD2
compared with other exonucleases (highlighted in the green box). Conserved residues are colored orange. (B) Structural comparison of EXD2-exo (red) and
WRN-exo (blue) in ribbon representation positioned in the same orientation.Helices4 and5 ofWRN-exo are arranged in a parallel manner (see arrows),
but the equivalent helices (5 and 6) in EXD2-exo are organized in an antiparallel fashion, resulting in significant conformational changes between helix
6 and the C-terminus (swapped in the EXD2-exo dimer; see also Supplementary Figure S6). (C) Close-up view of the structural superimposition of
EXD2-exo andWRN-exo. To highlight the roles of helices 5−7 of EXD2 in dimerization and formation of the active site, the structure of the composite
exonuclease domain of EXD2 (red and gray) formed by domain swapping is aligned with the WRN-exo monomer (blue). Helices of WRN-exo are labeled
in black boxes. (D) SEC chromatogram of EXD2-exo mutants N198P and 198−201. The experimental details are the same as in Figure 2C. (E) Time-
dependent exonuclease activity of EXD2mutants N198P and198−201. A 1.5 Msample of mutant protein was incubated with 0.25 M5-FAM-labeled
50-mer ssDNA for 1, 5, 15, or 30min at 37◦C and analyzed by non-denaturing TBE-PAGE. (F) EXD2 self-association assay in live cells. To analyze whether
the full-length and exonuclease domain of EXD2 can physically associate in full-length EXD2 in vivo, full-length human EXD2-V5-Avitag (AP) was co-
transfected with Flag-tagged full-length EXD2 (EXD21−621-Flag) or exonuclease domain of EXD2 (EXD21−295-Flag) in HEK293 cells (left, samples 1
and 2). The Avitag of EXD2-V5-AP can be biotinylated by co-transfection with BirA-NES (cytosol) for pull-down assays using SA-beads. Mutant version
of the exonuclease domain (EXD21−295, N198P-Flag) was used as control (left, sample 3). As negative controls, the bait protein EXD21−621-V5-AP was
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bacterial biotin ligase (BirA-NES) was also recombinantly
expressed in the same cells for the selective biotinylation
of Avitag of EXD21–621-V5-AP for streptavidin (SA)-bead
pull-down (Figure 3F, left) (23). After biotinylation follow-
ing addition of biotin (10 M) overnight, cells were lysed
and biotinylated EXD21–621-V5-APwas collected using SA-
coatedmagnetic beads. Subsequentwestern blotting of anti-
V5 revealed that enrichment of biotinylated EXD21–621-V5-
APwas achieved using the SA-beads (Figure 3F, right, anti-
V5 WB), and EXD21–621-Flag was also enriched using SA-
beads bound to EXD21–621-V5-AP (Figure 3F, right, sam-
ple 1, anti-Flag WB). We also checked that EXD21–295-
Flag, which contains the sequence of EXD2 from the N-
terminal TM domain to the exonuclease domain, was also
co-enriched with pulled-down EXD21–621-V5-AP (Figure
3F, right, sample 2, anti-Flag WB). However, in the same
conditions, the enrichment level was significantly com-
promised for the N198P single point EXD21–295 mutant
(EXD21–295, N198P-Flag), which was shown to be eluted ex-
clusively as a monomer in SEC experiments (Figure 3F,
right, sample 3, anti-Flag WB). We confirmed that the co-
enrichment of Flag-tagged protein did not occur in negative
control experiments lacking expression of the bait protein
EXD21–621-V5-AP (Figure 3F, right, sample 4−6, anti-Flag
WB). This result implies that the fully functionalized exonu-
clease domain of EXD2 forms a homodimer in live mam-
malian cells.
The EXD2-exo active site
Like other DEDDy superfamily exonucleases, EXD2-exo
has two metal ions at the active site (Figure 4A, site A is re-
ferred to as [MA] and site B is referred to as [MB] in the crys-
tal structure of EXD2-exo) (9). Although the crystallization
solution contained 200 mM calcium acetate, sodium rather
than calciumwas bound toEXD2-exo, suggesting that Ca2+
is not a genuine ion supporting activity in EXD2-exo (Fig-
ure 4A and SupplementaryFigure S8A). Indeed, EXD2was
inactive in the presence of calcium (Figure 2B and D). Con-
sistent with other DEDDy exonucleases, two metal ions are
coordinated by the catalytic core residues Asp108, Glu110,
Asp171, Tyr242 and Asp246 (Figure 4A and Supplemen-
tary Figure S8A). Among these, Tyr242 and Asp246 are
from helix 7′ of the opposing molecule in the EXD2-exo
dimer, as described above.
To further examine whether the metal specificity and ac-
tivity of EXD2 may be related to the structure of the active
site, we determined crystal structures of EXD2-exo in com-
plex withMn2+,Mg2+, (d)GMP plusMn2+ or (d)GMP plus
Mg2+ (Figure 4B−H and Supplementary Figure S8B−H).
The Mn2+ ion was found only in site MA in the absence
of dGMP, which is a mimic for the exonuclease product
of DNA (Figure 4B). However, two Mn2+ ions were dis-
tinctly observed at bothMA andMB sites in the presence of
dGMP, although electron density representing dGMP was
disordered in the structure (Figure 4D). Interestingly, Mg2+
ions were only found at siteMB regardless of the presence of
dGMP (Figure 4C and E). The MA site is occupied by two
H2O molecules when EXD2-exo is incubated with Mg2+
alone, while no ions (except for a single H2Omolecule) were
observed at the MA site when EXD2-exo was mixed with
both Mg2+ and dGMP (Figure 4C and E). Moreover, when
crystals are soaked in a solution containing both Mn2+ and
Mg2+, Mn2+ and Mg2+ ions are separately coordinated at
only theMA andMB sites, respectively (Figure 4F). In sum-
mary, Mg2+ ions were not definitively located at theMA site
that is key for exonuclease activity, and this unexpected ob-
servation might explain why EXD2 is inactive toward DNA
substrates in the presence ofMg2+ (Figure 2B andD). Inter-
estingly, when crystals of EXD2-exo were soaked in a solu-
tion containing Mg2+ and GMP, a known ribonucleotide
mimic of the RNase product, Mg2+ ions were located at
both MA and MB sites (Figure 4G). We assume that the 2′-
OH group of GMP might assist in this ion (MA) capture.
This hypothesis is supported by the fact that 2′-deoxyGMP,
which lacks the OH group corresponding to the ‘ordered
water molecule’, cannot bind to and assist in the capture of
a second Mg2+, resulting in only Mg2+ in the same site, as
observed in unsoaked crystals. This result is consistent with
the above data showing that EXD2 can cleave RNA in the
presence ofMg2+ ion (Supplementary Figure S3). Likewise,
Mn2+ ions were coordinated at both metal-binding sites in
the presence of GMP (Figure 4H).
Structural basis for the metal and substrate specificity of
EXD2-exo
Structural studies on EXD2-exo revealed that the metal co-
ordination influences whether DNA or RNA substrates can
be cleaved. We were therefore intrigued by the molecular
basis by which EXD2-exo displays metal ion coordination
and substrate (DNA or RNA) specificity, unlikeWRN-exo,
even though the two proteins share high structural simi-
larity. The major difference between EXD2-exo and other
DnaQ family exonucleases is that the active site of EXD2-
exo is organized as a domain-swapped dimer (Figures 3B
and 4; Supplementary Figure S6) (9,19–22). In particular,
helix 7′ is one of the main structural elements provided by
the opposing molecule in the EXD2-exo dimer. We specu-
late that this unusual active site organization might provide
structural flexibility via helix 7′. Moreover, the highly con-
served loop connecting helices 6′ and 7′ of EXD2-exo
was disordered in all structures determined in this study,
unlike the equivalent region in WRN-exo that is well or-
dered (Figure 3B) (9). This presumably suggests that he-
lix 7′ may be more flexible in EXD2-exo than in WRN-
exo. In fact, based on the crystal structures, helix 7 adopts
two conformations, depending on metal coordination, un-
like other DnaQ family exonucleases (9). As highlighted in
Figure 4A, C and E, helix 7′ forms a slightly bent struc-
ture whenMn2+ is not bound to theMA site. In more detail,
when metal ions are absent, or when a sodium ion is bound
to the MA site, the distance between side chains Tyr242 and
Asp246 in EXD2-exo is ∼6 A˚, which seems to be too far
to facilitate enzymatic action, consistent with the observed
lack of exonuclease activity under these conditions (Figure
4A, C and E). However, the distance narrowed to ∼3.8 A˚
when manganese was bound at the MA position (Figure
4B, D, F and H). The manganese ion was coordinated by
the side chain of Asp246 and the hydroxyl group of Tyr242
through an ordered water molecule. These intimate inter-
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Figure 4. Structural basis for the metal and substrate specificities of EXD2-exo. (A−H) Schematic representations (left) based on the crystal structures
(right) for native and metal ions and (d)GMP soaked structures showing the substrate discrimination of EXD2-exo resulting from metal coordination: (A)
native crystal; (B) Mn2+; (C) Mg2+; (D) Mn2+ soaked with dGMP; (E) Mg2+ soaked with dGMP; (F) Mn2+ and Mg2+; (G) Mg2+ soaked with GMP; (H)
Mn2+ soaked with GMP. In right panels, 2Fo-Fcmaps were contoured at 1.0  and Fo-Fc difference maps were contoured at 3.0  (yellow) and -3.0  (red).
In left schematic figures, helices harboring active site residues involved in metal coordination are depicted as cylinders. The C-loop (residues 285−294) from
the opposing protomer in the dimer is drawn in worm representation. Black arrows indicate conformation changes occurring whenMn2+ ions are bound to
theMA site in the catalytic domain of EXD2-exo (see text for detailed mechanism). Active site residues are shown with ball and stick representation in right
panels. All structural elements provided by the opposing molecule in the EXD2-exo dimer are colored gray. Water, sodium, manganese and magnesium
ions bound to the active site are shown as red, yellow, purple and green spheres, respectively. (I) Schematic representation of native and metal-soaked
structures of human WRN-exo and Zn2+ soaked with sulfate (SO4) structure of mouse WRN-exo shown in the same orientation as in (A). While Tyr212
in hWRN faces away from the active site, the conserved Tyr206 in mWRN is rotated toward the active site in the presence of sulphate ions (gray), which
might act as a mimic of the substrate phosphate moiety. Color scheme of manganese and magnesium ions is the same as (A−H) and zinc ions bound to
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sulting in the straightening of this structural element. The
distance of 3.8 A˚ is likely short enough to support enzyme
catalysis by facilitating the cooperation of Tyr242, Asp246
and the ordered water molecule with the DNA substrate.
When Mg2+ plus GMP is bound to EXD2-exo, although
two Mg2+ ions are bound to the active site, this Mg2+ coor-
dination is unable to induce an equivalent conformational
change in helix 7′ (Figure 4G). We concluded that the 2′-
hydroxyl group of GMP might replace the ordered water
molecule, preventing the attraction of Tyr242 (Figure 4G).
The role of the C-segment in EXD2 metal selectivity
We therefore wondered why two magnesium ions could not
be simultaneously coordinated by EXD2-exo in the pres-
ence of DNA as a substrate. Structure analyses indicated
that the half coupling ofMg2+ toEXD2-exomight be due to
insufficient space to accommodate two Mg2+ ions. As sum-
marized in Figure 4A−H, the distance between C atoms
of Asp171 and Asp246 is ∼12.5−12.7 A˚ when the 7 helix
forms a kinked structure.However, this distance is increased
to∼13.4 A˚ when the helix adopts a straightened (extended)
structure caused by the coordination ofMn2+ at theMA site.
Nevertheless, a distance of∼13.4 A˚ might be insufficient for
bothMg2+ ions to bind to the active site at the same time. In
the previous structure of WRN-exo complexed with Mg2+
(PDB ID: 2FBX), the distance between equivalent atoms
is ∼13.9 A˚ (Figure 4I). Even though EXD2-exo may have
sufficient space, EXD2might not be able to actively increase
the distance to an appropriate size. The C-segment provided
from the opposing molecule in the EXD2-exo dimer forms
extensive contacts not only with helix 4 bearing Asp171,
but also with the central -sheet of the active site, and this
may block themovement of helix4, thereby hindering spa-
tial expansion of the active site (Figures 4 and 5A; Supple-
mentary Figure S7).
To test our hypothesis that the C-segment might play
a pivotal role in regulating metal coordination in EXD2-
exo, we generated truncated constructs excluding the C-
segment (Figure 5B). Surprisingly, EXD276–284 lacking the
C-loop that contacts the active site exhibited robust exonu-
clease activity with DNA as a substrate in the presence of
Mg2+ as well as Mn2+. By contrast, the EXD276–260 vari-
ant lacking the whole C-segment lost all ability to cleave
DNA (Figure 5C). In fact, the sequence of EXD276–260 (185
residues) precisely corresponds toWRN38–236 (199 residues)
that possesses full exonuclease activity (9). Nevertheless,
EXD276–260 completely lost exonuclease activity, implying
that theC-segment (residues 260–295) is absolutely required
for enzymatic activity of EXD2. Furthermore, we tested
whether the C-segment supports the structural integrity of
EXD2-exo by performing CD spectroscopy in the absence
and presence of Mn2+. As shown in Figure 5D, EXD2-exo
lacking theC-segment displayed a reduction inmelting tem-
perature by ∼15◦C compared with the wild-type protein,
suggesting that the C-segment of EXD2 does indeed con-
tribute to structural integrity and stability, unlike in other
DEDDy family exonucleases. Interestingly, the addition of
Mn2+ to the EXD276–284 variant recovered the melting tem-
perature to that of the wild-type protein (Figure 5D, right).
This is consistent with the data showing that EXD276–284
retained exonuclease activity in the presence of metal ions
(Figure 5C). Collectively, these results suggest that the C-
segment plays an important role in regulating the exonucle-
ase activity not only by restricting metal ion coordination,
but also by stabilizing the overall conformation.
The EXD2-exo substrate-binding site
As described above, even in the crystal structures of EXD2
in complex with (d)GMP, no apparent electron density cor-
responding to (d)GMP was found in the active site. There-
fore, we investigated the probable substrate-binding region
of EXD2-exo by superimposing the structure of EXD2-
exo over that of trinucleotide-bound KF-exo, since the
substrate-binding site of WRN-exo was analyzed previ-
ously using a similar approach (9). The overall geometry
of residues in the active site of EXD2-exo is more similar to
that inWRN-exo than inKF-exo (Figure 6A).However, the
open conformation of Tyr212 (Tyr242 in EXD2-exo) in hu-
manWRN-exo was not observed in all structures of EXD2-
exo (Figure 4I) (9). Rather, Tyr242 of EXD2-exo projects
into the active site as shown in the structures of KF-exo
(Tyr497, PDB ID: 1KFS) and mouse WRN-exo (Tyr206,
PDB ID: 2E6L), and facilitates enzyme catalysis via an or-
dered water molecule and Mn2+ (Figure 6A) (8,19). In ad-
dition, the composite model suggests that the side chain of
Arg226 directly stacks against the basic ring of the last nu-
cleotide. The equivalent Arg190 in mWRN-exo forms a H-
bond with the oxygen atom of the basic ring. Instead, the
side chains of Phe473 inKF-exo andCys191 inmWRN-exo
play a similar role by positioning the last nucleotide. Lys185
in mWRN-exo is believed to be important for substrate
binding (8). However, the equivalent residue in EXD2-exo
(Lys221) is not visible in the electron density map and is
presumably disordered. Significantly, based on the model,
the Arg190 of helix 5 in EXD2-exo directly contacts the
ribose ring of the first nucleotide of the trinucleotide and
likely stabilizes the overall structure of the ligand (Figure
6A). Arg190 is absolutely conserved among members of the
EXD2 family, but is absent from mWRN-exo and KF-exo
(Figure 6A and Supplementary Figure S5).
We identified the substrate-binding region by alanine-
scanning mutagenesis. As shown in Figure 6B and C,
R226A single point mutants of EXD2-exo and tEXD2
lost all exonuclease activity, suggesting that Arg226 plays
a key role in binding substrate nucleotides. Furthermore,
as demonstrated for Lys185 in mWRN-exo (8), mutation
of the equivalent Lys221 in EXD2 affected the exonucle-
ase activity. Although this residue is not visible in the struc-
ture of EXD2-exo, it is obvious that it is also responsible for
substrate recognition. Finally, mutation of Arg190 in both
EXD2-exo and tEXD2 resulted in variants unable to cleave
DNA substrates (Figure 6B and C).
Analysis of surface electrostatic potential revealed that
EXD2-exo has a positively charged patch located just be-
neath the active sites (Figure 6D). This patch is mainly com-
posed of Arg190, Arg195 and Arg197 from helix 5, and
these residues are highly conserved among species (Supple-
mentary Figure S5). We therefore infer that substrates to be
cleaved might enter the catalytic site through this positively
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Figure 5. The C-segment is required for metal specificity and stability of the exonuclease domain. (A) Close-up view of the C-segment composed of 8 and
the C-loop. The metal-binding active site of EXD2-exo is enclosed by the C-segment of the other molecule in the dimer and is restricted spatially. (B) To
test the role of the C-segment in regulating the metal specificity, two truncated constructs (EXD276–260 and EXD276–284) were generated. (C) Metal cation-
dependent exonuclease activities of EXD276–260 and EXD276–284. Protein (2.5 M) was incubated with 0.25 M 5-FAM-labeled 50-mer ssDNA for 1 h at
37◦C and analyzed by non-denaturing TBE-PAGE. (D) Far-UV CD spectra of EXD2-exo (dimer and monomer), EXD276–260 and EXD276–284 from 190
to 260 nm (left). Thermal unfolding curves of EXD2-exo (dimer and monomer), EXD276–260 and EXD276–284 were measured by CD spectroscopy without
and with 5 mMMnCl2 (middle and right). Melting temperatures without MnCl2 were as follows: EXD2-exo (dimer) = 64.6◦C, EXD2-exo (monomer) =
65.2◦C, EXD276–284 = 51.6◦C, EXD276–260 = 50.3◦C. Melting temperatures with 5 mMMnCl2 were as follows: EXD2-exo (dimer) = 65.7◦C, EXD2-exo
(monomer) = 66.4◦C, EXD276–284 = 65.6◦C, EXD276–260 = 54.5◦C.
binding was verified by biochemical data (Figure 6B and
C). Additionally, we confirmed that mutation of Arg195 or
Arg197 impaired enzymatic activity (Figure 6E). As men-
tioned above, the structure of helix 5 is extended, and this
structural change seems to be essential for the formation
of the EXD2-exo dimer (Figure 3A and B). In fact, if he-
lix 5 is kinked, as is the case in WRN-exo and KF-exo,
EXD2-exo forms a monomer, which could prevent EXD2-
exo from forming a positively charged surface of sufficient
length to guide substrate entry. In fact, mutation of equiv-
alent residues in WRN and KF did not affect exonuclease
activity (Supplementary Figure S9).
In contrast to WRN-exo and KF-exo, it is noteworthy
that EXD2-exo has two active sites per dimer, related by 2-
fold symmetry (Figure 6D). The distance between the two
active sites is ∼46 A˚. Unfortunately, at present it is difficult
to explain why EXD2 has two catalytic sites that are closely
associated, but future biochemical studies should address
the role of this unusual catalytic domain arrangement. Nev-
ertheless, it is clear that formation of the EXD2 dimermight
be important for recruiting substrates to the active site by
providing a positively charged patch of sufficient length.
DISCUSSION
In this study, we first determined the crystal structure of the
human EXD2 exonuclease domain, revealing a novel struc-
ture in which the catalytic site is generated by chimeric ar-
rangement of molecules in a domain-swapped dimer (Fig-
ure 2). Dimeric exonucleases have been proposed in sev-
eral previous studies (24–27). However, this is the first re-
port of an exonuclease domain that is only active when
the enzyme is oligomerized. We also revealed the forma-
tion of a dimeric structure that might generate a positively
charged groove of sufficient length to guide substrate entry
in EXD2 (Figure 6).Moreover, this unusual active site orga-
nization and the presence of a unique C-segment could en-
dow EXD2 with the novel ability to discriminate between
DNA and RNA substrates via metal cation coordination
(Figures 4 and 5). In fact, EXD2 only digests RNA and
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Figure 6. Dimerization of EXD2-exo is important for substrate binding. (A) Close-up views showing trinucleotide-bound EXD2-exo (left), mWRN-exo
(middle) and KF-exo (right) in the same orientation to compare substrate-binding regions. Structural models were generated by superimposing structures
of EXD2-exo (soaked with Mn2+ and dGMP, from this study) and mWRN-exo (PDB ID: 2E6L) with the structure of trinucleotide-bound KF-exo (PDB
ID: 1KFS). In EXD2-exo, the two protomers are colored red and gray. The trinucleotide (yellow) and the side chains contacting the substrate are shown in
ball-and-stick representation. Nitrogen and oxygen atoms are colored blue and red, respectively. (B) Exonuclease activity of EXD2-exo mutants (R190A,
K221A and R226A). Mutant proteins (from the left, 0.5, 1 and 2 M) were mixed with 5-FAM-labeled ssDNA as described in Figure 2B. (C) Exonuclease
activity of tEXD2 mutants (R190A, K221A and R226A). The tEXD2 mutant proteins (from the left, 0.05, 0.1 and 0.2 M) were analyzed as described in
Figure 2B. (D) Electrostatic potential of the EXD2-exo molecular surface. The dimeric interface formed by the 5–5′ crossover beneath the active sites
generates a highly positively charged groove. Based on the trinucleotide-bound EXD2-exo model (A) combined with nuclease activity analyses (B and
C), putative substrate-binding pathways are indicated by arrows. The electrostatic potential was calculated using the Adaptive Poisson-Boltzmann Solver
(APBS) (39) and visualized (-4 kT/e, red, to +4 kT/e, blue) with PyMol (https://pymol.org/2/, version 1.7.4.4). (E) Exonuclease activity of EXD2-exo
mutants (R195A and R197A). Experimental procedures were the same as in panel (B).
drolyzes both DNA and RNA when Mn2+ ions are bound
(Figure 2 and Supplementary Figure S3). This is consistent
with a previous study in which EXD2 was suggested to act
as an RNase in the presence of Mg2+ in mitochondria (4).
In addition to substrate discrimination, the dimeric orga-
nization might confer the ability to regulate catalytic activ-
ity because the exonuclease activity of EXD2 appears to be
turned on only following self-association. Given that EXD2
is a membrane protein that is tightly anchored to the mi-
tochondrial membrane, it might be geometrically difficult
for molecules to associate with each other, suggesting that
EXD2might not always be active. It has not yet been tested
whether the two EXD2 molecules are associated within the
intra-mitochondrial membrane (homotypic interaction) or
through inter-membrane interactions (heterotypic interac-
tion) between two neighboring mitochondria (Supplemen-
tary Figure S10). In the latter case, EXD2might be involved
in mitochondrial tethering or mitochondrial dynamics such
as fusion events (3,28–30). In any case, the geometrical re-
striction indicated herein implies that the activity of EXD2
could be modulated by unknown cellular factors.
EXD2 is an important player in the DNA double-strand
break repair system (1). However, its biological role in the
nucleus has been contradicted by its mitochondrial local-
ization revealed in this and other studies (3,4). Thus, iden-
tification of its sub-mitochondrial localization is crucial to
understanding its role in mitochondria. Mitochondrial ma-
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tion, and it was concluded that it processes messenger RNA
within mitochondria (4). Very recently, however, Hensen
et al. provided further evidence of the OMM localization of
EXD2using proteinaseKdigestionwith isolatedmitochon-
dria (3). In the present work, we confirmed OMM localiza-
tion using a proximity labeling approach and APEX2-EM
imaging (Figure 1). Furthermore, we revealed that EXD2
contains anN-terminal single TMdomain that anchors it to
the OMMand a C-terminal domain that is mainly localized
to the cytosolic face of the OMM (Figure 1 and Supplemen-
tary Figure S1). These results suggest that the exonuclease
domain of EXD2 may have a novel function at the OMM
that has not yet been proposed.
Due to the absence of known DNA populations near the
OMM,we propose that EXD2might be involved in the pro-
cessing of RNA in the vicinity of the OMM. In particular,
we speculate that EXD2 might be involved in the biogen-
esis of Piwi-interacting RNA (piRNA) since the OMM is
recognized as a hub for processing piRNA, which is cru-
cial for germ cell development (29,31). Our hypothesis is
supported by the published data showing that germ stem
cell attrition is significantly accelerated in EXD2-deficient
ovaries of drosophila (4). Moreover, EXD2 is also highly
expressed in reproductive organs in human (32). In theGtex
portal (33), EXD2 expression is reportedly higher in testes
and brain than in other tissues. Because many piRNA bio-
genesis proteins, such as PIWIL1, TDRKH andMitoPLD,
are overexpressed in testes for the generation of the large
amounts of piRNAneeded to protect the genetic stability of
germ cell lines (34), a similar testis-specific expression pat-
tern of EXD2 in humans could indicate its possible involve-
ment in piRNA biogenesis. In the process of piRNA bio-
genesis, we further speculate that EXD2 could function as a
Trimmer, which digests the 3′ ends of pre-piRNAmolecules,
although PNLDC1 (35) and EXD3 (also known as Nibbler
in drosophila) (36) have been proposed to be Trimmers in
different models. As regards its possible role in piRNA bio-
genesis, it is intriguing to suggest that the homotypic dimer
of EXD2 may engage in functional interactions with the
homodimeric complex of MitoPLD at the OMM, which
also contains a signal anchoring the TM helix at the N-
terminus (37). The heterotypic interaction mode of EXD2
might function at the inter-mitochondrial cement, which is
observed in spermatogenesis inmammals (38). Future work
will be required to address the role that dimerization of the
EXD2 exonuclease domain may play in regulating physio-
logical function.
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